Welltower Inc. $WELL Stock Sold by Factory Mutual Insurance Co.

Factory Mutual Insurance Co. lowered its position in Welltower Inc. (NYSE:WELL) by 13.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 164,020 shares of the real estate investment trust’s stock after selling 26,030 shares during the period. Factory Mutual Insurance Co.’s holdings in Welltower were worth $37,764,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in WELL. Revolve Wealth Partners LLC increased its position in Welltower by 3.3% during the 2nd quarter. Revolve Wealth Partners LLC now owns 1,392 shares of the real estate investment trust’s stock worth $316,000 after purchasing an additional 45 shares during the period. Cornerstone Financial Management LLC lifted its holdings in shares of Welltower by 3.5% in the 2nd quarter. Cornerstone Financial Management LLC now owns 1,318 shares of the real estate investment trust’s stock valued at $299,000 after buying an additional 45 shares during the period. Family Wealth Partners LLC lifted its holdings in shares of Welltower by 1.3% in the 2nd quarter. Family Wealth Partners LLC now owns 3,678 shares of the real estate investment trust’s stock valued at $835,000 after buying an additional 48 shares during the period. Natural Investments LLC boosted its stake in shares of Welltower by 3.0% in the second quarter. Natural Investments LLC now owns 1,673 shares of the real estate investment trust’s stock valued at $379,000 after buying an additional 48 shares in the last quarter. Finally, West Family Investments Inc. boosted its stake in shares of Welltower by 1.9% in the second quarter. West Family Investments Inc. now owns 2,569 shares of the real estate investment trust’s stock valued at $583,000 after buying an additional 48 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Insider Transactions at Welltower

In other news, Director Andrew Gundlach bought 5,000 shares of the firm’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the completion of the transaction, the director owned 30,000 shares in the company, valued at $7,261,800. This trade represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. Corporate insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on WELL. Weiss Ratings lowered Welltower from a “buy (b-)” rating to a “hold (c)” rating in a report on Wednesday, October 28th. Scotiabank raised their target price on Welltower from $244.00 to $251.00 and gave the company an “outperform” rating in a report on Wednesday, September 2nd. UBS Group reissued a “buy” rating and issued a $269.00 target price on shares of Welltower in a report on Tuesday, October 27th. Royal Bank Of Canada boosted their target price on shares of Welltower from $238.00 to $260.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. upgraded shares of Welltower from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $230.00 to $260.00 in a research report on Thursday, September 24th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $259.81.

Welltower Trading Up 0.9%

Shares of WELL opened at $241.10 on Wednesday. Welltower Inc. has a twelve month low of $180.97 and a twelve month high of $255.20. The company has a current ratio of 3.16, a quick ratio of 3.16 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $176.88 billion, a P/E ratio of 104.37, a PEG ratio of 1.15 and a beta of 0.79. The firm’s 50-day moving average is $233.51 and its two-hundred day moving average is $218.75.

Welltower (NYSE:WELL) last posted its quarterly earnings results on Monday, October 26th. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.03. The company had revenue of $3.72 billion during the quarter, compared to the consensus estimate of $3.64 billion. Welltower had a net margin of 12.08% and a return on equity of 3.61%. The company’s revenue for the quarter was up 38.4% on a year-over-year basis. During the same period last year, the firm earned $1.34 EPS. On average, research analysts predict that Welltower Inc. will post 6.51 earnings per share for the current fiscal year.

Welltower Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 19th. Investors of record on Tuesday, November 10th will be issued a dividend of $0.85 per share. The ex-dividend date of this dividend is Tuesday, November 10th. This represents a $3.40 annualized dividend and a yield of 1.4%. Welltower’s payout ratio is currently 147.19%.

Welltower Company Profile

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.